News and Announcements
123gaming CEO Interview
- Published April 20, 2015 10:43AM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
123gaming is an award winning real-money betting operator that has overcome significant barriers to entry, and generated around $2.4 million to date.
The group has proven the concept for an innovative business model built on solid foundations of unique proprietary technology, as well as technology based customer acquisition tools and partnerships to drive low Costs Per Customer Acquisition (CPA) versus Customer Lifetime Value (LTV).
Existing revenue streams and customer acquisition tools include:
- a fully-legal US licensed and based online betting website called 123bet.com
- a unique real money bet type available online and to betting venues and racetracks across the $11bn United States horse racing betting market – the 123racing Wager.
- customized and fully-managed online freeplay betting contests for major racetrack and media customers/partners
In September 2014 the company soft launched 123bet.com generating around $2.1 million in online betting turnover to date, adding to around $370,000 from 123racing wagers at racetracks and OTBs (Off-track betting venues).
The Company’s goal is to become a leading social skill gaming provider to a global pools betting industry segment worth $90bn pa, utilizing existing distribution partners and further industry relationships to roll-out to five countries by 2019.
Please listen to CEO Mr Rob Earle to find out more about 123 Gaming.
Executive Interviews
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
